Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CD24 targeting with NK‐CAR immunotherapy in testis, prostate, renal and (luminal‐type) bladder cancer and identification of direct CD24 interaction partners

FEBS Journal(2023)10.1111/febs.16880Source: DataRank Database

CD24 targeting with NK‐CAR immunotherapy in testis, prostate, renal and (luminal‐type) bladder cancer and identification of direct CD24 interaction partners is a research paper published in FEBS Journal (2023). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

Linked data & code

pxd

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.47)OA: hybridTopics (56)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

David Thomas ORCID,Margaretha A. Skowron ORCID,Felix Bremmer ORCID,Markus Eckstein ORCID,Anja Stefanski ORCID

Live enrichment

PubMed:37254618 PMC:PMC11129509 OpenAlex:https://openalex.org/W4378760118

Deutsche Forschungsgemeinschaft

Grant: NE 1861/8‐1

Deutsche Gesellschaft für Urologie

Grant: Eisenberger‐Stipendium

National Institutes of Health

Grant: NIH/NCI R01‐CA75115

Wilhelm Sander-Stiftung

Grant: 2016.041.1/0.2

NCI NIH HHS

Grant: R01 CA075115

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

Studienstiftung des Deutschen Volkes

FWCI

1.47

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

hybridLicense: other-oa

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.16880

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.16880

publisherhttps://febs.onlinelibrary.wiley.com/doi/pdf/10.1111/febs.16880

journalhttps://doi.org/10.1111/febs.16880

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37254618

Fields of Study

Immune Cell Function and InteractionBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers03 medical and health sciences0302 clinical medicineHumansMaleCD24 AntigenCell Line, TumorImmunotherapyKiller Cells, NaturalProstateReceptors, Chimeric AntigenReceptors, Natural Killer CellTestisUrinary Bladder NeoplasmsUrologic NeoplasmsUrogenital Neoplasms

MeSH Terms

Receptors, Chimeric AntigenUrinary Bladder NeoplasmsHumansImmunotherapyKiller Cells, NaturalMaleProstateTestisUrogenital NeoplasmsUrologic NeoplasmsCell Line, TumorCD24 AntigenReceptors, Natural Killer Cell

Keywords

Cancer researchCD24Viability assayFlow cytometryChemistryCD44BiologyCellMolecular biologyBiochemistryImmunotherapyUrologic MalignanciesTesticular Germ Cell TumourMaleUrologic NeoplasmsReceptors, Chimeric AntigenProstateCD24 AntigenKiller Cells, NaturalUrinary Bladder NeoplasmsCell Line, TumorTestisHumansReceptors, Natural Killer CellUrogenital Neoplasms

Sustainable Development Goals

SDG 0: Good health and well-being